Search
New frontiers in neuroscience: 10 years of progress at UTSW’s O’Donnell Brain Institute: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2025/oct-obi-10-year-anniversary.html
In her new office at UT Southwestern Medical Center, Ceci Verbaarschot, Ph.D., sits among unpacked boxes and discusses the intricacies of a brain-computer interface she is developing. The device is designed to restore sensation and movement in the upper limbs of people who are paralyzed from the
Aspirin use best for those with high coronary calcium, low risk of bleeding : Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2020/aspirin-use-best-for-those-with-high-coronary-calcium.html
An X-ray test commonly used to assess hardening of the arteries could help doctors decide whether the benefits of taking aspirin to prevent a first heart attack or stroke outweigh the risks of bleeding from its use, UT Southwestern research suggests.
Home-time metric needed to judge hospital readmissions, studies suggest : Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2020/home-time-metric-needed-to-judge-hospital-readmissions.html
Two new studies suggest Medicare’s system of penalizing hospitals if too many patients are readmitted within 30 days should also look at whether the patients were well enough to remain in their home during that time.
UT Southwestern leads national efforts around childhood blood disorders : Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2020/ut-southwestern-leads-national-efforts.html
Studies highlight how collaborative research can improve the diagnosis and treatment of childhood blood disorders such as aplastic anemia and MDS
Revised clinical trial rules during COVID-19 pandemic may benefit patients, survey shows: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2020/revised-clinical-trial-rules-during-covid-19.html
The COVID-19 pandemic has led to new rules and expectations for clinical trials.
UTSW scientists identify mechanism crucial for COVID-19 virus replication: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/august-covid-19-virus-replication.html
A team led by UT Southwestern researchers has identified how SARS-CoV-2, the virus that causes COVID-19, builds a structure called the RNA cap that’s critical for successful viral replication.
Study reveals molecular ‘switch’ that turns on inflammation in obesity: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2026/jan-molecular-switch-inflammation-obesity.html
A team led by UT Southwestern Medical Center researchers has uncovered a molecular pathway that links obesity to widespread inflammation, providing long-sought insight into why obesity increases the risk of Type 2 diabetes, cardiovascular disease, fatty liver disease, and certain cancers.
UT Southwestern biochemist Steven McKnight, Ph.D., earns Lasker Award
https://www.utsouthwestern.edu/newsroom/articles/year-2025/sept-lasker.html
Steven McKnight, Ph.D., Professor of Biochemistry at UT Southwestern Medical Center, has been awarded the Albert Lasker Basic Medical Research Award.
UTSW named Specialized Program of Research Excellence for liver cancer
https://www.utsouthwestern.edu/newsroom/articles/year-2025/sept-liver-cancer.html
The Liver Tumor Program at UT Southwestern Medical Center’s Harold C. Simmons Comprehensive Cancer Center has been selected by the National Cancer Institute as a Specialized Program of Research Excellence (SPORE).
UTSW first in Texas to offer novel treatment for rare eye cancer that spreads to the liver : Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2026/jan-novel-treatment-rare-eye-cancer.html
A team at UT Southwestern Medical Center this week became the first in Texas and neighboring states to successfully perform a novel procedure to deliver whole-liver chemotherapy to treat metastatic uveal melanoma, a rare and deadly eye cancer.